The deubiquitinase USP4 stabilizes the SCFFBXO24 ubiquitin E3 ligase to regulate immunity in experimental pneumonia Authors: Ilknur Yurtsever, Daniela Farkas, Alex Cornwell, Jessica A Joseph, Siying Xu, Joshua A Englert, Joseph S Bednash, James D Londino, Benjamin S Johnson, Rama K Mallampalli Published: 2026 ABSTRACT AbstractThe ubiquitin E3 ligase SCFFBXO24 targets key proteins for degradation that regulate important biological processes, but the mechanisms controlling cellular concentrations of its receptor subunit, F-box only protein 24 (FBXO24), remain unknown. Here, Haemophilus influenzae type B (HiB), an important cause of pneumonia, protects FBXO24 from lysosomal degradation in THP-1 macrophage cells by reducing its ubiquitylation levels. We identified that the ubiquitin-specific peptidase 4 (USP4) mediates FBXO24 deubiquitylation and stabilization in response to HiB infection in a TLR4 receptor-dependent manner. In experimental HiB pneumonia, either nanoparticle delivery of encapsulated USP4 siRNA or targeted genetic disruption of Fbxo24 in mice led to increased alveolar mononuclear cells coupled with reduced bacterial loads, attenuated pulmonary edema and decreased lung injury severity compared to control mice. Collectively, these findings demonstrate the ability of a bacterial pathogen to exploit a deubiquitylation mechanism to preserve cellular levels of an E3 ligase component, thereby impairing innate host defense responses.Subject terms: Diseases, Respiratory distress syndrome Introduction In eukaryotic cells, the degradation of proteins is primarily executed by the ubiquitin-proteasome system (UPS)1. The process of protein ubiquitylation is orchestrated by a series of enzymatic reactions involving a ubiquitin-activating enzyme (E1), a ubiquitin-conjugating enzyme (E2), and a ubiquitin ligase (E3). Target proteins that are ubiquitylated by the E3 ligases are subsequently degraded by a large protein complex, the 26S proteosome, or within the lysosome. Among ~600 E3 ligase genes estimated to be present in humans2, the mechanism and function of ubiquitylation mediated by the SCF (Skp1-Cul1-F-box protein) complex have been extensively studied3. A crucial receptor component within the SCF apparatus that engages substrates is the F-box protein. One member of the F-box protein family, FBXO24, has recently been described with several features: (i) it is an evolutionarily conserved chromatin-binding protein4–6; (ii) it is essential for sperm flagellum formation and male fertility7,8; and (iii) it has critical functions as a tumor suppressor in breast carcinoma progression9. Recent studies also implicate FBXO24 in the regulation of mitochondrial function10,11 and demonstrate the ability of this F-box protein to modulate immune responses10. Given its emerging role in regulating diverse biological processes, a gap exists in studies investigating molecular factors that control FBXO24 cellular concentrations. Ubiquitylation is a dynamic and reversible process in which deubiquitinating enzymes (DUBs) serve as antagonists by removing ubiquitin moieties from substrate proteins12. Based on sequence homology, DUBs can be classified into eight classes: ubiquitin-specific proteases (USPs), ovarian tumor proteases (OTUs), Machado-Joseph domain-containing proteases (MJDs), ubiquitin C-terminal hydrolases (UCHs), motif interacting with ubiquitin-containing novel DUB family (MINDYs), JAMMs (JAB1/MPN/MOV34), monocyte chemotactic protein-induced protein (MCPIP) families, and the ZUFSP DUB family13. Among these, the USP family is the largest, consisting of nearly 60 members that display a variety of substrate specificities, regulatory mechanisms and modification preferences. The ubiquitin-specific protein 4 (USP4) plays a crucial role in the removal of both monoubiquitylation and polyubiquitylation chains (including K48 and K63 conjugated ubiquitin linkages) from specific target proteins. USP4 is involved in several cellular processes including pre-mRNA splicing14, cell growth and differentiation15, immune responses16, signaling pathways17, TGF-β signaling18, Wnt/ β -catenin signaling19, the NF-κB signaling pathway20–22 and hyaluronan synthesis23. In this study, we demonstrate that the stability of the SCF E3 ubiquitin ligase subunit, FBXO24, is increased following Haemophilus influenzae type B (HiB) infection in THP-1 macrophage cells. This crucial induction occurs through the deubiquitylation process mediated by USP4. Further, we observed that HiB-induced stabilization of FBXO24 protein is regulated via a Toll-like receptor 4 (TLR4)-dependent process. In an experimental murine pneumonia model using HiB, full or partial genetic disruption of Fbxo24 or Usp4 depletion led to increased alveolar inflammatory cells and reduced bacterial burden, underscoring the biological relevance of this F-box protein-deubiquitinase network in innate immunity. Further, adoptive transfer of Fbxo24-depleted bone marrow-derived macrophages compared to wild-type control cells reduced bacterial burden and lessened severity of lung injury during experimental pneumonia. These findings provide unique insight into the regulatory mechanisms impacting FBXO24 abundance in the context of innate host defense. Results HiB infection increases FBXO24 protein levels in human and mouse myeloid cells To assess the impact of HiB infection on FBXO24 protein levels, primary human alveolar macrophages (HAMs) isolated from failed donors and primary human CD14+ differentiated macrophages were infected with HiB (10, multiplicities of infection [MOI]) for up to 8 h. We detected a significant increase in immunoreactive FBXO24 protein levels in HAMs, while CD14+ macrophages showed a trend toward increased FBXO24 protein levels (Fig. 1a–c). FBXO24 silencing confirmed that the immunoreactive band observed on immunoblots represents the F-box protein (Supplementary Fig. 1) as shown previously10, and the effects of HiB are selective for FBXO24 (Supplementary Fig. 2a, b and Fig. 1j). FBXO24 mRNA levels remained unchanged in HAMs over the course of infection and other HiB serotypes had no effect on the FBXO24 transcript in THP-1 cells (Fig. 1d and Supplementary Fig. 3). To further assess dose-dependency, CD14+ macrophages were infected with increasing MOIs (0.1–25) of HiB, which again showed a trend toward increased FBXO24 protein levels, although responses varied between experiments (Fig. 1e, f). In addition, primary bone marrow-derived macrophages (BMDM) were isolated from C57BL/6 J mice, differentiated, and infected with various MOI of HiB. FBXO24 protein levels increased in proportion to the HiB MOI (Supplementary Fig. 4a, b). To further investigate mechanisms, we used THP-1 macrophages-like cells. THP-1 macrophage cells were infected with the pathogen (MOIs 0.1–25) for 6 h. We detected an increase in FBXO24 protein levels without significant changes in FBXO24 mRNA levels when compared to uninfected cells, similar to HAM cells (Fig. 1g–i). Analysis of kinetics in FBXO24 mRNA and FBXO24 protein expression in THP-1 cells showed that HiB significantly increased FBXO24 protein levels by 8 h while FBXO24 gene expression levels remained unchanged over time (Fig. 1j–l). Further, HiB did not alter FBXO24 protein levels in BEAS-2B cells (Fig. 1j and Supplementary Fig. 2c). Similar results were observed in the B-cell-derived leukaemia cell line, BLaER1 cells (Supplementary Fig. 4c, d). To determine if the increase in FBXO24 protein levels due to HiB infection in THP-1 cells was serotype-dependent, cells were infected with serotype A (HiA) and non-typeable H. influenzae (MOI 10, [NTHi]) for up to 8 h or 6 h, respectively. Infection with H. influenzae type A did not significantly alter FBXO24 protein levels in THP-1 cells; however, infection with the non-typeable strain of H. influenzae resulted in a reduction in FBXO24 protein levels (Fig. 1m–o). To determine whether the elevation in FBXO24 protein levels observed in myeloid cells by HiB infection was cell-specific, we infected several human primary pulmonary cells, including human small airway epithelial cells (HSAEC), human bronchial epithelial cells (HBEC), human pulmonary artery endothelial cells (HPAEC), human lung endothelial cells (HULEC), and human lung fibroblasts (HLF), with the pathogen (0.5–25 MOIs) (Supplementary Fig. 4e, f). In these other primary human lung cells, infection with HiB did not cause significant changes in FBXO24 protein levels. Thus, HiB infection stimulates FBXO24 protein accumulation in cells derived from a myeloid lineage in a serotype-dependent and cell-specific manner. HiB triggers FBXO24 protein accumulation. A Human alveolar macrophages (HAMs) and CD14+ macrophages show increased FBXO24 protein after HiB infection. B, C Densitometry of immunoblot results from (A), from top **P = 0.0030,***P = 0.0007, **P = 0.0011. D FBXO24 mRNA levels in HAMs infected with HiB (10 MOI). E FBXO24 protein levels in human CD14+ macrophages infected with various MOIs of HiB for 6 h. F Densitometry of the immunoblot results in (E). G FBXO24 protein levels in THP-1 cells infected with various MOI of HiB for 6 h. H Densitometry of the immunoblot results in (G) from top *P = 0.0345, *P = 0.0364, *P = 0.0362. I FBXO24 mRNA levels in THP-1 macrophage cells infected with various MOI of HiB for 6 h. J Levels of F-box proteins in THP-1 and BEAS-2B cells infected with HiB (MOI = 10). K Densitometry of the immunoblot results of FBXO24 protein levels in THP-1 cells in (J). ****P < 0.0001, **P = 0.0020, *P = 0.0102. L FBXO24 mRNA levels in THP-1 cells infected with HiB for up to 8 h, P = 0.9451. M FBXO24 protein levels following infection with H. influenzae type A ([HiA], top blot) or infection with H. influenzae nontypeable ([NTHi], bottom blot) (MOI = 10), in THP-1 cells. N, O Quantification by densitometry of immunoblot results of FBXO24 protein levels in (M). (P = 0.3859) for HiA infection (N), **P = 0.0029, *P = 0.0462) for NTHi infection (O). Densitometry calculated as fold change normalized to the loading control.The mRNA levels were determined by RT-qPCR and normalized to ACTB as a reference gene. Data are represented as mean ± SD [n = 3 in (C, D, F, I, L, N), n = 4 in (H, O), n = 7 in (B, K) as biological independent experiments]. B, D, F, H, I employed one-way ANOVA with Dunnett’s multiple comparisons. Two-way ANOVA with Tukey’s comparison test was used for K, M–P, R. B, K used Kruskal–Wallis test with Dunn’s multiple comparison. Source data are provided as a Source Data file. HiB-induced increase in FBXO24 requires TLR4 To elucidate if a released product from HiB affects FBXO24 protein levels, HAMs were incubated for 6 h in cell-free conditioned media (CFCM) obtained from HiB cultures (0–50 MOI). We observed that the increase in FBXO24 protein levels was similar to the increase after HiB infection (Fig. 2a, b). These results were confirmed in THP-1 cells (Fig. c–f). As pathogen-associated molecular patterns are recognized via innate immune receptors, we next tested whether Toll-like receptor (TLR) agonists could replicate this effect in THP-1 and BLaER1 macrophages at indicated concentrations (Supplementary Fig. 5a). Stimulation of THP-1 cells with LPS and FSL-1, which are TLR-4 and TLR2/6 agonists, respectively, increased FBXO24 protein levels in both THP-1 cells (Fig. 2g) and in BLaER1 cells (Supplementary Fig. 5b), although effects of LPS were more modest. To investigate the role of the TLR4 receptor on FBXO24 protein by HiB infection, we infected murine alveolar macrophages (MAMs) derived from Tlr4 knockout (KO) or wild-type (WT) mice with HiB for 6 h. Here, HiB-induced accumulation of FBXO24 protein was significantly attenuated compared to control cells (Supplementary Fig. 5c, d). These findings were also validated in HAM cells transfected with siRNA targeting the TLR4 gene (Supplementary Fig. 5e, f). Together, these results implicate bacterial-released components that may stabilize FBXO24. To this end, lipooligosaccaride (LOS), a major component of the outer cell membrane of HiB, and a putative TLR2/6 and 4 ligand, was investigated. To assess LOS signaling on FBXO24 levels, we used blocking antibodies (to TLR4 and TLR2) in THP-1 macrophage cells. Indeed, compared to the isotype-matched control antibody, TLR4 receptor antagonism (Fig. 2h, i) resulted in a significant reduction in FBXO24 levels in cells compared to blockade of the TLR2 receptor (Fig. 2j, k). To confirm the mechanistic link between LOS and TLR4, THP-1 cells were treated with recombinant TLR4/myeloid differentiation protein 2 (MD2), a TLR4 decoy receptor that was preincubated with LOS. Following incubation of LOS-TLR4MD-2 complex with cells, we observed a statistically significant decrease in FBXO24 protein levels compared to the mock control (Fig. 2l, m). Additionally, analysis of supernatant collected from these experiments showed significantly lower levels of pro-inflammatory cytokines IL-1β and TNFα in proportion to increasing TLR4/MD-2 concentrations compared to the control group (Fig. 2n). To assess TLR4-dependent NF-κB and IRF pathways, we used THP-1 dual TLR4 knockout (KO) and control THP-1 dual cells, both equipped with two inducible reporter genes, allowing simultaneous measures of NF-κB and IRF activities (Fig. 2o, p). NF-κB-dependent responses to various stimuli were measured by activity of secreted embryonic alkaline phosphatase (SEAP) in the culture medium. IRF-dependent responses to stimuli were measured by activity of secreted luciferase in cell culture media. THP-1 dual TLR4 KO cells exhibited increased NF-κB activity in response to HiB infection, CFCM, and the Pam3CysSerLys4 (PAM) TLR2/1 agonist, compared to control. However, no NF-κB activity was detected in response to LOS in THP-1 dual TLR4 KO cells (Fig. 2o). Further, none of the stimuli, including HiB infection, triggered IRF responses in THP-1 dual TLR4-KO cells compared to THP-1 dual control cells (Fig. 2p). Importantly, we were unable to detect any changes in FBXO24 protein levels in response to any of the stimuli used in THP-1 dual TLR4 KO cells (Fig. 2q, r). THP-1 macrophage cells were also transfected with siRNA targeting RelA, the gene encoding p65, major subunit of the NF-ĸB pathway. RelA knockdown demonstrated that p65 is required for HiB-induced increase in FBXO24 protein levels (Supplementary Fig. 6a, b). Together, these results suggest that HiB-induced FBXO24 accumulation requires TLR4 signaling, whereas HiB-induced NF-ĸB activation that triggers cytokine release occurs independently of TLR4. HiB induction of FBXO24 protein is TLR4 dependent. (A) FBXO24 protein levels in HAMs exposed to cell-free conditioned media (CFCM) at various HiB MOI for 6 h. B Quantification by densitometry from (A), from top *P = 0.0214, *P = 0.0481. C FBXO24 protein levels in THP-1 cells after HiB infection or CFCM exposure. D Quantification by densitometry from (C), *P = 0.0129. E FBXO24 protein levels in THP-1 cells exposed to CFCM at various HiB MOI for 6 h. F Quantification by densitometry from (E), from top *P = 0.0175, *P = 0.0384. G FBXO24 induction in BLaER1 cells by TLR receptor agonists. H FBXO24 protein levels in THP-1 cells treated with TLR4 blocking antibody (IgG control), followed by lipooligosaccharide (LOS) treatment for 6 h. I Quantification by densitometry from (H), from top ***P = 0.003, ***P = 0.002, **P = 0.0016, **P = 0.0032, **P = 0.0014. J FBXO24 protein levels in THP-1 cells treated with TLR2 blocking antibody, followed by LOS treatment for 6 h. K Quantification by densitometry from (J), ***P = 0.0004. L FBXO24 protein levels in THP-1 cells cultured with rhTLR4/MD-2 and pretreated with LOS for 1 h. M Quantification by densitometry from (L), **P = 0.0030, *P = 0.0253, ***P = 0.0007. N IL-1β and TNFα levels in THP-1 cells incubated with rhTLR4/MD-2 and LOS; from top ****P < 0.0001, **P = 0.0024, ****P < 0.0001, ****P < 0.0001 for IL-1β, and from top ****P < 0.0001, **P = 0.0038, ****P < 0.0001, ****P < 0.0001 for TNFα. O NF-kB activity by secreted alkaline phosphatase (SEAP) assay in THP-1 dual TLR4-KO and control cells after stimuli for 6 h. P IRF activity by Lucia luciferase assay in THP-1 dual TLR4-KO and control cells after stimuli for 6 h. Q FBXO24 protein levels in THP-1 dual TLR4-KO and control cells after stimuli for 6 h. R Quantification by densitometry from (Q),****P < 0.0001, *P = 0.0158. Densitometry calculated as fold change normalized to the loading control. Data are represented as mean ± SD [n = 3 in (B, D, F, I, K, O, P, R), n = 4 in (M, N) as biologically independent experiments]. One-way ANOVA with Dunnett’s test for B, D, F, I, M, and R; Tukey’s test for N; two-way ANOVA with Tukey’s test for K, O, P. Source data are provided as a Source Data file. HiB inhibits lysosomal degradation of FBXO24 protein in myeloid cells To examine the effect of HiB infection on the stabilization of the FBXO24 protein, HAMs were treated with cycloheximide (CHX), a protein synthesis inhibitor, throughout the infection process. The half-life of the endogenously expressed FBXO24 protein was significantly extended under bacterial infection conditions compared to the control group; here, cells were pre-treated with HiB to enhance the FBXO24 protein levels at start of the CHX chase (Fig. 3a, b). These results were also observed in stably overexpressed FBXO24-Flag THP-1 cells, where HiB infection prolonged FBXO24 protein half-life (Fig. 3c, d). As a specificity control, cMyc exhibited rapid turnover not affected by HiB infection. To investigate the degradation pathway of FBXO24, we used inhibitors targeting lysosomes, proteasomes, or the E1 activating enzyme in cell culture experiments. Notably, THP-1 cells treated with the lysosomal inhibitor bafilomycin A1 (Baf-A1) showed a significant accumulation of FBXO24 protein (Fig. 3e, f), while a more modest increase in immunoreactive FBXO24 was observed over time after incubation with MLN-7243, an inhibitor of the ubiquitin-activating enzyme. (Fig. 3e). We further evaluated the effect of infection on FBXO24 polyubiquitylation in FBXO24-Flag overexpressing THP-1 cells. FBXO24 polyubiquitylation decreased with increasing HiB MOI and infection duration (Fig. 3g–j). Additionally, in THP-1 cells stably overexpressing FBXO24-Flag, we confirmed that the basal degradation of FBXO24 protein occurs in the lysosome. Using immunofluorescent staining and confocal microscopy with anti-Flag and lysosome-associated membrane protein 1 (LAMP1) antibodies, we observed a significant reduction in cells with lysosomal FBXO24 localization (defined as LAMP1/Flag double-positive cells) after HiB infection compared with mock infection (Fig. 3k, l). To assess whether the HiB-induced increase in FBXO24 protein may be due to impaired lysosomal integrity, cell viability and lysosomal activity were examined in THP-1 cells following HiB infection. No changes in cell viability or lysosomal activity were observed in HiB-infected THP-1 macrophage cells compared to the control group (Supplementary Fig. 7a, b). To identify polyubiquitylation acceptor sites within FBXO24 protein after HiB infection, cell lysates from FBXO24-Flag overexpressing THP-1 cells were processed for immunoprecipitation (IP) followed by tandem mass spectrometry of post-translational modifications. The analysis identified a total of seven ubiquitin acceptor sites within FBXO24 protein (Fig. 3m, n). Ectopic expression of FBXO24-Flag variants harboring K → R substitutions in cells, specifically FBXO24K30R and FBXO24K112R, showed that these expressed proteins displayed an extended t½ compared to wild-type FBXO24, suggesting that these are putative polyubiquitylation acceptor sites (Fig. 3o, p). Hence, collectively the data show that FBXO24 undergoes site-specific polyubiquitylation and lysosomal degradation, a process reduced by HiB infection. HiB inhibits FBXO24 polyubiquitylation and lysosomal degradation. A HAMs were pretreated with or without HIB (10 MOI) for 4 h and endogenous FBXO24 half-life assayed using cycloheximide (CHX). B FBXO24 decay curves generated from immunoblots in (A) with (**P = 0.0022). C FBXO24 half-life in FBXO24-Flag overexpressing THP-1 cells treated with CHX under the basal and HiB infected conditions. A control FBXO3 shows no change in half-life. D FBXO24 decay curves generated from immunoblots in (C), **P = 0.0066. E FBXO24 protein levels in THP-1 cells treated with MLN-7243 (5 µM), MG132 (20 µM), or Baf-A1(100 nM). F Quantification by densitometry of immunoblots for Baf-A1 in (E), **P = 0.0034, *P = 0.022. G, H FBXO24 polyubiquitylation levels in FBXO24-Flag overexpressing THP-1 cells infected with HiB for 6 h (G) or over time (MOI = 10) (H), assessed by Flag IP and immunoblotting. I, J Quantification by densitometry of (G, H), *P = 0.0203 for (I), and *P = 0.0477 for (J). K Confocal images of FBXO24 (Flag) and LAMP1 co-staining in FBXO24 overexpressing THP-1 cells under native and HiB-infected conditions for 6 h, treated with leupeptin (Leu), followed by staining with anti-Flag, anti-Lamp1, and DAPI, indicating co-localization of FBXO24 with Lamp1 in the lysosome (arrows) and with DAPI in the nucleus. Scale bar = 20 μm. L FBXO24/Lamp1 co-localization are quantitated from 26 to 52 cells/group, n = 2 biologically independent group, (***P = 0.0002, ****P < 0.0001). M Map of the Mass Spectrometry (MS) of ubiquitylated lysine residues in stably FBXO24 overexpressing THP-1 cells infected with and without HiB. N Representative MS spectrum validating a ubiquitylated lysine residue. O, P Immunoblots and decay curves of FBXO24 WT and K → R mutants after CHX treatment. The densitometric analysis involved calculating the fold change (FC) after normalizing the immunoblot signals to the loading control. Data are represented as mean ± SD [n = 3 in (B, D, P), n = 3-5 in (I), n = 4 in (F, J) as biologically independent experiments]. B used two-way ANOVA with Sidak’s multiple comparison test. D, F, I, and J used one-way ANOVA with Dunnett’s multiple comparison test, L with Tukey’s comparison test. Source data are provided as a Source Data file. USP4 deubiquitylates FBXO24 We hypothesized that HiB stabilizes FBXO24 protein by reducing its polyubiquitylation mediated by a DUB. A library containing 96 DUB siRNAs was used to identify specific DUB enzymes responsible for maintaining the basal levels of FBXO24 protein. We measured luciferase activity in cell lysates after DUB siRNA transfection in HiBiT tagged FBXO24 overexpressing BEAS-2B cells. In essence, the HiBiT tag used to detect luciferase activity reflects steady-state FBXO24 protein levels. We employed it in some genetic studies in BEAS-2B cells primarily to exploit its ability to generate reporter constructs and execute loss-of-function and gain-of-function studies, which are substantially more challenging in THP-1-like macrophages. The siRNA screening results revealed a statistically significant decrease in the luciferase activity associated with the following DUBs: USP4, USP20, USP36, USP40, USP41, and UBL5 after DUB siRNA transfection in cells compared to the siRNA control group (Fig. 4, top and lower graphs). Although other DUBs potentially regulate FBXO24 protein, these DUB families exerted more modest effects in our assays (Fig. 4, lower graphs). By repeating the experiment with siRNAs targeting these DUBs, we demonstrated that the USP4 and USP20 DUBs target FBXO24, shown by a significant decrease in luciferase activity after USP4 and USP20 knockdown (Supplementary Fig. 8). Further, overexpressing USP4-Flag (Fig. 5a, b) or knockout of USP4 using a CRISPR-Cas9 system (Fig. 5c, d) in THP-1 cells differentially modulated the F-box protein’s t1/2 in cells compared to control demonstrating that the cellular abundance of this DUB is crucial in regulating FBXO24 protein levels. Effective silencing of USP4 was validated in USP4 immunoblotting using HAM cells (Supplementary Fig. 9a, b). Importantly, HiB induction of FBXO24 protein was effectively abrogated in HAM cells depleted of USP4 using CRISPR-Cas9 editing (Fig. 5e, f). Likewise, we detected a significant decrease in HiB-induced FBXO24 protein levels in CRISPR-Cas9 USP4 knockout THP-1 cells that stably overexpressed FBXO24 (Fig. 5g, h). In these USP4-depleted cells, FBXO24 polyubiquitylation was increased compared to sgControl THP-1 macrophages. (Fig. 5i, j). To further investigate effects on endogenous FBXO24 polyubiquitylation, we performed TUBE assays to capture ubiquitylated proteins in control and USP4 overexpressing THP-1 cells, showing modest, but significantly reduced polyubiquitylated endogenous FBXO24 in USP4 overexpressing cells compared to control (Supplementary Fig. 10a, b). Identification of candidate DUBs regulating FBXO24 stability. Shown are luminescence signals quantified in FBXO24-HiBiT overexpressing BEAS-2B cells after transfection with a DUBs siRNA library for 3 days using Nano-Glo HiBiT Lytic Detection Reagent. The DUBs siRNA library contains five families of human deubiquitinases, USP ubiquitin-specific proteases, UBL/UCH ubiquitin carboxyl-terminal hydrolases, OTU ovarian tumor proteases, Josephins, and Jamm/MPN; and metalloenzyme DUBs. ****P < 0.0001 for graph of USP, from top **P = 0.0012, **P = 0.0020 for graph of Josephins, *P = 0.0205 for graph of Jamm/MPN, from top **P = 0.0078, ****P < 0.0001, and **P = 0.0040 for graph of UBL/UCH, and from top **P = 0.0054, *P = 0.0498, *P = 0.0111 for graph of OTU. Data are represented as mean ± SD (n = 3, biologically independent experiments). Statistical analysis was by one-way ANOVA with a multiple comparison test. Source data are provided as a Source Data file. USP4 targets FBXO24 for deubiquitylation. A FBXO24-Flag overexpressing THP-1 cells were transduced with USP4-Flag lentivirus or control mock lentivirus, treated with CHX for the indicated time points and processed for immunoblotting. B Quantification of FBXO24 t1/2 by densitometry from (A). n = 3 biologically independent samples. Statistical significance determined by a two-way ANOVA with Šídák’s multiple comparisons test (*P = 0.0172). C FBXO24-Flag overexpressing THP-1 cells were transduced with sgCntrl or USP4-sgRNA lentivirus, treated with CHX and protein levels were measured by immunoblotting. D quantification of FBXO24 t1/2 from (C). Statistical significance was determined by a two-way ANOVA with Sidak’s multiple comparison test (*P = 0.0438). E HAMs were infected with or without HiB (10 MOI), and the effect of USP4 knockout was assayed by immunoblotting. F Quantification by densitometry of immunoblots in (E), ***P = 0.0003, **P < 0.0021. G Cells were infected with or without HiB, and effect of USP4 knockout using CRISPR-Cas9 in stably transfected FBXO24-overexpressing THP-1 cells was assayed by immunoblotting. H Quantification by densitometry of immunoblots in (G), ****P < 0.0001, ***P = 0.0002. I Stably USP4 KO and control FBXO24 overexpressing THP-1 cells were treated with Baf-A1 for 4 h to accumulate ubiquitylated proteins; the levels of FBXO24 polyubiquitylation were measured by immunoblotting. J Quantification by densitometry of immunoblots in (I), *P = 0.0461. K Phagocytosis assay in USP4 knockout and sgCntrl THP-1 cells, ****P < 0.0001. The densitometric analysis involved calculating the fold change (FC) after normalizing the immunoblot signals to the loading control. Data are represented as mean ± SD [n = 3 in (B, D, F), n = 4 in (J), n = 5 in (H) as biologically independent experiments, n = 5 from n = 2 biologically independent samples in (K)]. H, K Used a one-way ANOVA with Tukey’s multiple comparison test. F, J used a one-way ANOVA with Dunnett’s multiple comparison test. Source data are provided as a Source Data file. We next determined whether the USP4-FBXO24 axis is involved downstream of TLR4 activation. Indeed, stimuli (LPS, CFCM, HiB) to variable degrees increased FBXO24 protein levels in THP-1 cells compared to TLR4 KO THP-1 cells, whereas USP4 protein levels remained unchanged (Supplementary Fig. 11a). These results suggest that TLR4 modulates USP4 by increasing its catalytic activity. Using ubiquitin-vinyl sulfone probes designed to detect active deubiquitinases in cell lysates, we determined that levels of active USP4 in control cells infected with HiB were statistically significantly higher compared to TLR4 KO THP1 macrophage cells (Supplementary Fig. 11b, c). Thus, the HiB-induced increase in FBXO24 protein levels requires TLR4 signals leading to USP4 activation. Macrophages eliminate pathogens through their phagocytic activities24. We performed a phagocytosis assay to examine the effect of USP4 gene knockout on the phagocytosis capabilities of THP-1 cells. We observed a significant increase in phagocytosis capabilities of USP4 knockout THP-1 cells compared to control group cells (Fig. 5k). The data suggest that USP4 selectively mediates the effects of HiB ability to stabilize FBXO24 protein but does not exclude other DUBs that could coordinately regulate levels of the F-box protein. USP4 appears to have a key biologic role in modulating bacterial clearance. HiB infection increases FBXO24 protein in vivo To investigate the effects of HiB infection in vivo, we used a mouse lung pneumonia model. We infected C57BL/6 J female mice with low-dose (5 × 105 cfu/mouse) or high-dose (5 × 107 cfu/mouse) HiB, with PBS as a control. At 24 h post-infection, mice were euthanized and bronchoalveolar (BAL) fluid and BAL cells were collected for analysis (Fig. 6a). Lung tissue was harvested for measurement of Fbxo24 and USP4 protein and mRNA levels after infection showing an increase in Fbxo24 protein levels (Fig. 6b, c) without significant changes in Fbxo24 mRNA levels (Fig. 6d) in HiB infected mice compared to the control group. Further, HiB infection did not result in alterations in USP4 protein or mRNA levels (Fig. 6e, f) compared to the control group. Fbxo24+ BAL cells were significantly increased in the high-dose HiB infection group compared to the control group (Fig. 6g, h). To investigate which BAL myeloid cell population drives this increase, we assessed Fbxo24 expression in resident alveolar macrophages (RAMs; CD45+ CD11b+/− CD64+ Ly6G− Siglec F+(high)), monocyte-derived macrophages (MDMs; CD45+ CD11b+/− CD64+ Ly6G− Siglec F+(low)), and bone marrow-derived monocytes (BMDMs; CD45+ CD11b+/− CD64+ Ly6G− Siglec F− MHC-II− Ly6C+ (high)), revealing a shift in the ratio RAMs:MDMs by significantly decreasing Fbxo24+ RAMs and increasing Fbxo24+ MDMs in HiB infected mice. A trend towards increased percentage of Fbxo24+ Ly6high BMDMs in BAL cells was seen with both HiB doses (Fig. 6i–k, Supplementary Fig. 12a–e) and the total numbers of Fbxo24+ Ly6high BMDMs in BAL cells were significantly increased under HiB infection in both HiB doses (Supplementary Fig. 12c). In addition, Fbxo24+ neutrophils (CD45+ CD11b+ Ly6G+) in BAL were also significantly increased after HiB infection (Supplementary Fig. 12a, f). The gating strategy used to identify these BAL immune cell populations is described (Supplementary Fig. 13). HiB infection resulted in a significant increase in total BAL cells and bacterial load in lung tissue (Fig. 6l, m). Lung wet-to-dry weight ratio (W/D), a measure of pulmonary edema, was significantly elevated in high-dose HiB-infected mice compared to PBS controls (Fig. 6n). BAL fluid revealed significantly elevated levels of pro-inflammatory cytokines, IL-6 and TNFα levels following high-dose HiB infection, with trends toward increased IL-1β. Notably, anti-inflammatory IL-1RA was significantly increased in BAL fluid after HiB infection compared to control mice (Fig. 6o). Thus, HiB-induced Fbxo24 accumulation in vitro is recapitulated in an experimental pneumonia, with selective upregulation in monocyte/macrophage subpopulations. HiB increases FBXO24 protein in experimental pneumonia. A C57BL/6 J mouse was intranasally infected with HiB at 5 × 105 cfu/mouse (HiB low) or 5 × 107 cfu/mouse (HiB high) for 24 h; PBS used as control. Bronchoalveolar lavage (BAL) and lung tissue were harvested 24 h post-infection. B Protein levels of FBXO24 and USP4 in lung tissue; FBXO3 used as specificity control. C Densitometry of the immunoblots from (B). PonceauS as loading control, (****P < 0.0001, *P = 0.0165) D Fbxo24 mRNA levels in lung tissue. E, F USP4 protein and mRNA levels. G Representative flow cytometry plots showing FBXO24+ BAL cells (top row), Siglec Fhigh resident alveolar macrophages (RAMs) and Siglec Flow monocyte-derived macrophages (MDMs) (middle row), and Ly6Chigh bone marrow-derived monocytes/macrophages (below) across PBS, HiB low and high groups. H Quantification of FBXO24+ BAL cells as a percentage of live cells in (G), top row,**P = 0.0026. I Quantification of FBXO24+ BAL RAMs as a percentage of the SiglecF+ cells in (G, middle row), **P = 0.0049, *P = 0.0306. J Quantification of FBXO24+ BAL MDMs as a percentage of Siglec F+ cells (G, middle row), **P = 0.0053, *P = 0.0323. K Quantification of FBXO24+ in BMDMs as a percentage of the Siglec F− cells in (G, bottom row), P = 0.0545. L BAL total cell counts, from top ****P < 0.0001 **P = 0.0023,**P = 0.0097. M Colony-forming unit (CFU) assay for bacterial loads in lung tissue,***P = 0.0010. N Lung wet/dry weight ratio, from top *P = 0.0275 *P = 0.0200. O Heatmap of cytokines (pg/ml) in BAL fluid: IL-1RA **P = 0.0046, *P = 0.0131, IL-6 **P = 0.0032 (PBS vs HiB high), **P = 0.0036 (HiB low vs HiB high), and TNFα ***P = 0.0005, ***P = 0.0005 across PBS, HiB low, and HiB high groups. Data are represented as mean ± SD [n = 4 mice/group in (C–F, M–O), n = 4 (low) and n = 5 (PBS, high) mice/group in (H–L). C–F, L used a one-way ANOVA with Dunnett’s multiple comparison test. I–K, M–O used a one-way ANOVA with Tukey’s multiple comparison post-hoc test. H used a Kruskal–Wallis test. Source data are provided as a Source Data file. Created in BioRender. YURTSEVER, I. (2026) https://BioRender.com/6y7vft4. Fbxo24 disruption modulates innate immune responses in experimental pneumonia We infected Fbxo24+/+ wild-type (WT), Fbxo24+/− heterozygous and Fbxo24−/− knockout mice (female and male mice with C57BL/6 J background) with HiB, where PBS was used as a control. At 48 h post infection, mice were euthanized and assessed for lung injury (Fig. 7a). We observed an initial decrease in body weight 24 h after infection in all Fbxo24 genotypes. At 48 h post infection, Fbxo24−/− and Fbxo24+/− showed a significant body weight gain compared to Fbxo24+/+ in the HiB group(Fig. 7b). Despite weight recovery within these genotypes (Supplementary Fig. 14a), there was no survival advantage.BAL albumin levels showed no significant differences between genotypes after HiB infection (Supplementary Fig. 14b). Fbxo24−/− mice also showed a significant reduction in bacterial load compared to Fbxo24+/+ mice, while Fbxo24+/− mice showed an intermediate level of bacterial clearance (Fig. 7c). Histological analysis of lung tissues revealed markedly decreased inflammatory cell infiltration and alveolar damage in Fbxo24−/− HiB-infected mice compared to Fbxo24+/+ and Fbxo24+/− groups, indicating that loss of Fbxo24 attenuates HiB-induced lung infiltration (Fig. 7d). BAL fluid analysis showed significantly elevated proinflammatory cytokines and chemokines after HiB infection in Fbxo24+/+ compared to PBS-control Fbxo24+/+mice, including IL-1β, IL-6, IP-10 and TNF-α as well as MIP-1α and MIP-2, that are primarily secreted by macrophages to recruit neutrophils and other immune cells to sites of injury. Partial or complete Fbxo24 knockout mice showed a significant decrease in IL-1β, TNF-α, IL-17/IL-33, but remarkably a two-fold increase in IL1RA in Fbxo24−/− compared to Fbxo24+/+ after HiB infection (Fig. 7e). Lung W/D and injury scores were significantly lower in Fbxo24−/− mice compared to WT HiB-infected mice (Fig. 7f, g). Total BAL cell counts were significantly increased in Fbxo24−/− mice compared to Fbxo24+/+ mice, driven predominantly by increased mononuclear cells (MN), while neutrophils were significantly reduced in Fbxo24+/− mice (Supplementary Fig. 14c–e). Flow cytometry analysis of BAL cell populations showed a significant decrease in CD11b+Ly6G+ neutrophils with partial or complete depletion of Fbxo24 compared to WT mice after HiB infection (Supplementary Fig. 14f, g) and a trend towards a decrease of MDM cells and an increase of RAM cells with depletion of Fbxo24 (Supplementary Fig. 14h, i). We were able to detect increased Fbxo24+ monocytes/macrophages recruited to the lung after HiB infection from the blood/bone marrow (Fig. 6, Supplementary Fig. 12). To further investigate lung cell recruitment in HiB-induced pneumonia, we performed a macrophage depletion/reconstitution rescue experiment (Fig. 7h). Administration of clodronate-liposomes efficiently depletes splenic and bone marrow macrophages in C57BL/6 J mice25. We were able to achieve ~80% F4/80+ macrophage depletion in the spleen and ~60% F4/80+ macrophage depletion in the bone marrow 2 d after administration of clodronate-liposomes compared to control-liposomes (Supplementary Fig. 15a-d). In rescue experiments, we administered 1 × 106 CM-Dil-labeled BMDM intravenously from bone marrows of Fbxo24+/+ and Fbxo24−/− that were cultured in vitro with M-CSF for 7 d before administration. HiB infection occurred 2 d after reconstitution with Fbxo24+/+ (WT) or Fbxo24−/− depleted (KO) BMDM for 24 h. In both Fbxo24 BMDM groups, systemic depletion of F4/80+ splenic macrophages and a reduction of total lung MDMs in BAL was seen after clodronate treatment compared to control groups (Fig. 7i, Supplementary Fig. 15e, f). To confirm successful BMDM adoptive transfer, reconstituted cells were labeled with CM-DiI, a fluorescence cell label, prior to administration: flow cytometry analysis confirmed the presence of CM-DiI+ cells in BAL of reconstituted mice, with no significant difference in adoptive transfer efficiency between WT and KO BMDMs (Fig. 7j, k). The specificity of the Fbxo24 antibody used for flow cytometry was validated using BMDMs from Fbxo24+/+ or Fbxo24−/− mice, confirming a clear shift in fluorescence signal between genotypes with negligible isotype staining (Supplementary Fig. 16). Adoptive transfer of Fbxo24−/− KO BMDM cells to infected mice led to a significant reduction of bacterial load and reduced lung edema compared to WT cells (Fig. 7l, m). Key mediators in BAL fluid were significantly reduced by administration of Fbxo24−/− KO BMDMs, including MIP-1α, MIP-2, IL-6, as well as IL-1RA. (Fig. 7n). BAL albumin levels showed no significant differences between BMDM reconstituted groups, while total BAL cell counts were significantly reduced in Fbxo24−/− KO BMDM-reconstituted mice (Supplementary Fig. 17a, b). Histological analysis further confirmed attenuated lung injury in Fbxo24−/− BMDM-reconstituted mice with fewer inflammatory cells, especially neutrophils in the lung parenchyma (Fig. 7o, p, Supplementary Fig. 17c, d). Flow cytometry analysis further revealed that reconstitution of Fbxo24 KO BMDM resulted in significantly fewer neutrophils in BAL, alongside maintaining a high percentage of RAMs in the BAL. In contrast, administration of Fbxo24 WT BMDMs showed a marked shift in the RAM:MDM ratio in BAL with neutrophil predominance at high levels compared to Fbxo24−/− BMDM-reconstituted mice (Supplementary Fig. 17c–f). These results suggest that macrophage-associated FBXO24 expression modulates innate immune responses during HiB pneumonia. Specifically, Fbxo24-deficient macrophages appear to promote enhanced bacterial clearance and reduce severity of pulmonary injury. Fbxo24 gene disruption in mice blunts innate immunity. A Fbxo24 transgenic mouse was intranasally infected with HiB and euthanized 48 h post infection. B Body weight changes, *P = 0.0227, ***P = 0.0004. C–E Bacterial loads (C), H&E lung sections (D) and cytokines from BAL (E), IL-1β **P = 0.0011 (+/+PBS vs +/+HiB), *P = 0.0293 (+/+PBS vs +/−HiB), IL-17 *P = 0.0243 (+/+PBS vs +/+HiB), *P = 0.0338 (+/+PBS vs +/−HiB), IL-33 *P = 0.0269 (+/+PBS vs +/+HiB), *P = 0.0229 (+/+PBS vs +/−HiB), *P = 0.0185 (+/+PBS vs −/−HiB), MIP-1 α *P = 0.0238 (+/+PBS vs +/+HiB), MIP2 P = 0.0085 (+/+PBS vs +/+HiB) [right panel], IL-RA **P = 0.0044 (+/+PBS vs −/−HiB), IL-6 *P = 0.0233 (+/+PBS vs +/+HiB), IP-10 ***P = 0.0010 (+/+PBS vs +/+HiB), ***P = 0.0005 (+/+PBS vs+/−HiB), *P = 0.0184 (+/+PBS vs −/−HiB), TGFβ1 *P = 0.0276 (+/+PBS vs −/−HiB), TNFα **P = 0.0061 (+/+PBS vs +/+HiB), *P = 0.0286 (+/+PBS vs −/−HiB) [right panel]. F Lung W/D ratio. G Lung injury score. H Schematic overview of the clodronate depletion/reconstitution studies. I MDM counts and J Flow cytometry of CM-DiI-labeled BMDMs in BAL cells. K CM-DiI⁺ live BAL cells. L, M Bacterial loads (L) and lung edema (M) after rescue using Fbxo24 KO BMDM. N BAL cytokine levels. IL-1β *P = 0.0360 (WT vs KO), MIP-1α **P = 0.0054 (WT vs KO), MIP-2 *P = 0.0170 (WT vs. KO) [left panel], and IL-1RA **P = 0.0088 (WT vs. KO), IL-6 **P = 0.0069 (WT vs. KO), **P = 0.0061 (control liposome vs. WT) [right panel]. O Lung injury score. P H&E lung sections. Scale bar, 200 μm. Data are represented as mean ± SD [n = 8 (WT-PBS in (B)), n = 4 (WT-PBS in (C)), n = 9 (WT-HiB), n = 10 (Het-HiB), n = 5 (KO-HiB) in (B, C), n = 4 (WT-PBS) in (E, G), n = 5–9 (WT-HiB), n = 5–6 (Het-HiB), n = 5–7 (KO-HiB) in (E), n = 5 (WT-HiB, Het-HiB and KO-HiB) in (G), n = 5 in (F), n = 3 (KO), n = 4 (WT) in (I, K–P), n = 5 (-+- group) in (I, L–P)]. Two-way ANOVA with Tukey’s test for B. One-way ANOVA with Tukey’s test for C, E–G, I–K, M, O. One-way ANOVA with Dunnett’s test for (L); Kruskal–Wallis test for (E); unpaired two-tailed Welch’s t test for (N). Source data are provided as a Source Data file. Created in BioRender. YURTSEVER, I. (2026) https://BioRender.com/a6o2r0h. USP4 knockdown modulates innate immune responses in HiB pneumonia Mannosylated lipid nanoparticles (MLNP) have been used to deliver microRNAs to alveolar macrophages by engaging the mannose receptor (CD206) on the cell surface26. We used this nanoparticle formulation to deliver small interfering RNAs targeting USP4 to alveolar macrophages. Prior to in vivo delivery, we conducted physiochemical characterization of particles and confirmed that murine macrophage cells (MH-S) express CD206 (Supplementary Figs. 18 and Fig. 8a). The MH-S cells were transfected with MLNPs loaded with siUSP4 or non-targeting (NTC) control siRNA at concentrations of 5 nM or 25 nM MLNP for 48 h and showed effective knockdown of Usp4 mRNA (Fig. 8b). To determine the biological role of USP4, we delivered 2.5 nmol of siUsp4-loaded MLNPs, or control nanoparticles loaded with scramble siRNA via intratracheal administration 6 h prior to HiB infection (5 × 107 i.t. cfu/mouse) in female C57BL/6 J mice (Fig. 8c). Mice were euthanized 24 h post infection for analysis. We observed a decrease in Usp4 mRNA levels after treatment with Usp4 siRNA-loaded MLNPs in mice infected with HiB compared to uninfected control mice (Fig. 8d). Using immunofluorescence staining to detect USP4, we observed a significant reduction in USP4 protein in BAL cells from mice treated with siUsp4-loaded MLNPs after HiB infection compared to uninfected control mice or infected mice treated with scramble-loaded MLNPs (Fig. 8e, f). Additionally, Usp4 mRNA levels in liver, heart, kidney, and spleen remained unchanged in all groups (Fig. 8g). Thus, alveolar macrophages are likely targeted in the lung, as we have shown previously using nanoparticle RNA gene transfer27. Usp4 knockdown in experimental pneumonia. A CD206 receptor expression on murine alveolar macrophage cells (MH-S). B Usp4 mRNA levels in MH-S cells transfected with nontargeting control (cntrl) or Usp4 siRNA (5 nM and 25 nM) naked or encapsulated in mannosylated lipid nanoparticles (MLNP). C The C57BL/6 J mice received siUsp4 or siNTC [non targeting control])-loaded MLNP intratracheally (i.t.) 6 h before infection with HiB (5 × 107 cfu/mouse) or PBS (control) for 24 h. D Usp4 mRNA levels in lungs of mice given siNTC or siUSP4 with or without HiB. E Confocal images of Usp4 protein in BAL cells; DAPI counterstain. Scale bar, 5 µm. F Quantification from (E). G Usp4 mRNA levels in mouse organs. H Representative flow cytometry plots of FBXO24 + BAL cells. I Quantification from (H). J CFU assay for lung tissue bacterial loads. K–N BAL total cells (K) and BAL mononuclear (MN) cells (L), BAL polymorphonuclear (PMN) cells (M). N BAL albumin levels between LNP groups. O BAL cytokines from mice given siUsp4 or siNTC with (+) or without (−) HiB. IL-6 **P = 0.0051 (NTC− vs NTC+), **P = 0.0021 (NTC−/Usp4+); TNFα ***P = 0.0004 (NTC−/NTC+), ***P = 0.0006 (NTC−/Usp4+); KC/GRO **P = 0.0039, (NTC−/NTC+), *P = 0.0167 (NTC−/Usp4+); IL12p70, **P = 0.0037 (NTC−/NTC+), *P = 0.0237 (NTC−/Usp4+); MCP1, *P = 0.0117 (NTC−/NTC+), *P = 0.0487 (NTC−/Usp4+); IL27, *P = 0.0141 (NTC−/NTC+); IL15, *P = 0.0137 (NTC−/NTC+), *P = 0.0263 (NTC−/Usp4+); MIP-1a **P = 0.0093 (NTC−/NTC+), *P = 0.0114 (NTC−/Usp4+); MIP-2 ****P < 0.0001 (NTC−/NTC+), ***P = 0.0001 (NTC−/Usp4+). P H&E lung images at low (scale bar: 500 μm, top row) and high (scale bar: 50 μm, lower row) magnification. Q Lung injury score in mice from (P). R Lung (W/D) ratio in mice is shown. Data are represented as mean ± SD [n = 3 (cntrl-5nM and USP4-5nM), n = 4 (other groups) in (B), n = 6 (NTC- and USP4 + ) in (D, G, I–O, Q), n = 5 (NTC-) in (F), n = 5 (NTC + ) in (D, F, G, I–O, Q), n = 6 (USP4 + ) in (F), n = 5 (NTC + ), n = 3 (USP4 + ) in (R)]. Statistical tests used one-way ANOVA with a multiple comparison test for B, D, F, I–N, Q, R. O Used one-way ANOVA with Holm-Šídák’s multiple comparisons test. Source data are provided as a Source Data file. Created in BioRender. YURTSEVER, I. (2026) https://BioRender.com/1idgs7g. Similar to prior experiments, Fbxo24+ cells were increased in BAL cells after HiB infection versus uninfected control groups. Mice treated with siUsp4-loaded MLNPs prior to HiB infection had significantly lower levels of Fbxo24+ BAL cells and Fbxo24 protein levels in BAL, as shown by Fbxo24 mean fluorescence intensity (MFI) measured by flow cytometry compared to control mice treated with control MLNPs (Fig. 8h, i, Supplementary Fig. 19a, b). To further characterize the effect of Usp4 knockdown on Fbxo24 protein levels across macrophage subpopulations, we assessed Fbxo24 MFI in SiglecF−low MDMs and SiglecF−high RAMs. Usp4 knockdown with siRNA MLNP treatment significantly reduced Fbxo24 MFI in both MDMs and RAMs compared to the HiB-infected siNTC group, confirming that USP4-dependent regulation of Fbxo24 occurs across distinct macrophage populations in vivo (Supplementary Fig. 19c–g). Notably, Usp4 knockdown mice showed a significant increase in bacterial clearance in post infection compared to mice that received control MLNPs (Fig. 8j). HiB infection increased total BAL cells, mainly MN, an effect accentuated with Usp4 knockdown compared control mice (Fig. 8k, l). HiB infection resulted in an increase in PMN cells in mice that received control MLNPs, an effect reduced after Usp4 depletion in mice (Fig. 8m). Total BAL albumin levels showed minimal changes in all groups (Fig. 8n). BAL fluid showed significantly increased pro-inflammatory cytokines IL-6, IL10, KC/GRO, IP10, and TNF-α after HiB infection compared to the control PBS-treated group. Notably, Usp4 knockdown mice infected with HiB showed a decrease in several pro-inflammatory cytokines together with less edema and histologic injury compared to HiB-infected mice treated with control MLNPs (Fig. 8o–r). Hence, these results show that the Usp4 knockdown in alveolar macrophages prior to HiB infection decreases Fbxo24 levels and mitigates neutrophilic infiltration and lung injury by enhancing bacterial clearance. Discussion In this study, we demonstrate that HiB infection promotes USP4-mediated deubiquitylation of the FBXO24 protein, thereby emphasizing the importance of deubiquitinase/F-box proteins in regulating host-pathogen interactions. Our findings reveal the following: (i) cellular accumulation of FBXO24 induced by HiB is serotype-specific and limited to myeloid cells, (ii) in THP-1 macrophage cells, this process requires TLR-4, while the regulation of the innate immune response to HiB occurs in a TLR-4 independent manner, (iii) FBXO24 protein stabilization appears to be mediated by USP4 activity in the setting of HiB infection in HAMs and macrophage cells, attenuating aspects of the necessary immune response, and (iv) biological disruption of the Fbxo24 or Usp4 gene in a HiB murine pneumonia model effectively decreased severity of lung injury by reducing bacterial burden and lung inflammation underscoring importance of this deubiquitinase-E3 ligase regulatory network in host defense (Fig. 9). These findings are the showing the ability of HiB to modulate the lifespan of a host protein using the ubiquitylation-deubiquitylation apparatus to either evade immune clearance or attenuate a host immune response. Cartoon showing USP4-FBXO24 signaling axis as an immune suppression mechanism in HiB-induced acute lung injury. The engagement of innate immune signaling pathways by HiB infection results in the upregulation of USP4 deubiquitylase activity within macrophages. Activated USP4 activity deubiquitylates FBXO24, prevents its lysosomal degradation and resulting in its aberrant intracellular accumulation. FBXO24 stabilization, in turn impairs macrophage-mediated host defense, resulting in exacerbated acute lung injury (red pathway). Conversely, USP4 depletion accellerates FBXO24 polyubiquitylation and degradation thereby mitigating lung injury (green pathway). Collectively, this model uncovers a unique post-translational regulatory mechanism in which the USP4-FBXO24 signaling axis functions as an innate immune suppression pathway in the context of bacterial pneumonia. Created in BioRender. YURTSEVER, I. (2026) https://BioRender.com/qhnokgs. FBXO24 plays a significant role in protein ubiquitylation and proteasomal degradation, particularly affecting immunity. FBXO24 regulates cellular energetics by polyubiquitylation of mitochondrial aspartyl-tRNA synthetase, which is crucial for maintaining mitochondrial integrity during immune responses10. We recently demonstrated that Fbxo24 globally-deficient mice (Fbxo24−/−) exhibit an exuberant immune response after P. aeruginosa infection10. We speculate that increased alveolar cellular responses seen here may involve perhaps immunoregulatory cells involved in resolution of inflammation (e.g., myeloid-derived suppressor cells etc.). The current observations differ in part, from our prior studies in the P. aeruginosa model, where a more pronounced cytokine response was seen that could be explained by the experimental conditions (timing of analysis, and type of pathogen10). Moreover, FBXO24 modulates transcription factors such as FOXK2, which regulates the expression of immunity-related genes, thus emphasizing its role in shaping innate immune signaling11. Hence, FBXO24’s ability to impair several innate immune responses supports its role as an immune suppressor. This is biologically relevant as severe pneumonia is associated with relative immune suppression28. Our findings here are in line with these prior observations; however, these results show an unrecognized mechanism whereby a pathogen extends the lifespan of an SCF E3 ligase component through its deubiquitylation to modulate innate immunity. Bacterial infections modulate the immune response by altering protein stability in several systems. For example, nontypeable H. influenzae infection in mice alters immunity in lung tissue by stimulating deubiquitylation of TNF-receptor-associated factor 6 and TNF-receptor-associated factor 7, components of TLR-2-dependent inflammatory pathways29. Nontypeable H. influenzae species also induce the association of the E3 ligase, Itch, with the Nedd4 family interacting protein 1 to enhance Itch E3 ligase function30. Further, E. coli infection in macrophages inhibits NF-κB signaling and downstream inflammatory responses by modulating the stabilization of lκBα, which inhibits NF-κB nuclear translocation31. Additionally, endotoxin enhances histone acetyltransferase binding to origin recognition complex 1 (HBO1) stability in THP-1 macrophage cells, which then modulates the transcription of pro-inflammatory genes32. Our observations further support the supposition that pathogens exploit mechanisms involving augmenting stability of proteins within the E3 ligase machinery to drive microbial virulence. Protein stabilization by DUBs via removing ubiquitin chains from target proteins is an exquisite, indispensable regulatory mechanism required for cell homeostasis that affects cell metabolism, differentiation, protein stability, and DNA repair33,34. USPs have pivotal functions in immune reactions, inflammatory diseases, metabolic syndromes, and infections mediated by post-translational processes35. Specifically, USP4 impacts NF-κB activation and downstream innate immune responses in several systems20,36,37. Interestingly, our results reflect an emerging paradigm whereby a DUB targets an E3 ligase. For example, USP4 inhibits p53 transcriptional activation by stabilizing ARF-BP1, the latter an E3 ubiquitin ligase17,38. The ovarian tumor DUB 7b stabilizes the E3 ligase TNF-receptor-associated factor 2, the latter a molecular input to NF-κB activation, cytokine production, and expression of anti-apoptotic genes30. The demonstration that other DUBs stabilize the F-box proteins FBW7 and SKP2 further illustrates potentially important interplay between SCF E3 ligase components and DUBs39,40. Studies have demonstrated the essential role of bacterial induction in the regulation of DUBs, suggesting that these enzymes are crucial for orchestrating cellular responses and partake in microbial pathobiology. Porphyromonas gingivalis, a key pathogen in the development of periodontitis, regulates USP4 in macrophages to alter RAB7A ubiquitylation, affecting lysosomal trafficking dynamics41. USP25 levels also correlate with Fusobacterium nucleatum colonization in human colorectal tumor biopsies, suggesting that USP25 may serve as a prognostic marker in gastrointestinal cancer42. Additionally, Salmonella enterica modulates the DUB, UCH-L5, in macrophages, triggering inflammasome activation for a more effective immune response43. In pneumonia models, the DUB cylindromatosis is activated by Streptococcus pneumoniae44, non-typeable H. influenzae29, and E. coli45. Here, we observed a unique ability of HiB infection to regulate the immune response by increasing USP4 activity of preformed enzyme without increasing USP4 protein levels. Nevertheless, there is mounting data indicative of various microbial pathogens activating DUBs. A unique biological finding of our studies shows that both disruption of the Fbxo24 gene or Usp4 depletion resulted in improved bacterial clearance coupled with resolution of experimental pneumonia. Importantly, following in vivo HiB infection, a dose-dependent accumulation of the Fbxo24 protein was observed in several BAL macrophage subpopulations, including RAMs, MDMs and BMDMs. Further, adoptive transfer of Fbxo24-depleted BMDMs after systemic depletion of monocytes/macrophages was sufficient to improve pulmonary bacterial clearance, reduce pro-inflammatory cytokines, and limit neutrophil accumulation, thereby reducing lung injury. Thus, it appears that macrophage-specific Fbxo24 plays a role in the suppression of innate immune responses. In fact, an unanticipated finding that USP4 silencing increased phagocytic activity by THP-1 macrophage cells suggests that this DUB, either independently or through FBXO24 stabilization, exerts deleterious effects on host immunity. The results are consistent with our observations that FBXO24 impairs mitochondrial energetics10; indeed, ATP is essential for macrophage phagocytosis and efferocytosis46,47. The results are of clinical significance as DUB small-molecule inhibitors are in development targeting bacterial clearance48. In addition, F-box proteins have emerged as potential targets for small-molecule inhibitors, as small-molecule inhibitors to several SCF E3 subunits modulate immune responses, highlighting their value as druggable targets3,49,50. Thus, targeting FBXO24 might shift the myeloid-derived lung population that enhances innate immune responses, including enhanced bacterial clearance. Overall, these results support a role for USP4-FBXO24 signaling as an immune suppression axis, and the current data uncovers a unique mechanism whereby this F-box protein has an extended lifespan in cells mediated by USP4 in response to H. influenzae. Methods Cell culture Human lung primary cells, human bronchial epithelial cells (HBECs, #CRL-4051), and human small airway epithelial cells (HSAECs, # PCS-301-010) were purchased from ATCC and were maintained according to ATCC recommendations. HULEC and human pulmonary artery endothelial cells (HPAECs) were kindly provided by Dr. Laszlo Farkas (OSU). Primary endothelial cells were cultured in early passages in EGM-2 MV supplemented with the microvascular endothelial cell BulletKit (#CC-3202, Lonza Bioscience, Walkersville). HLF were kindly provided by Dr. Mauricio Rojas (OSU) and cultured in early passages in DMEM supplemented with 10% FBS, HEPES, L-glutamine, penicillin/streptomycin. Human alveolar macrophages (HAMs) were obtained from lung explants from the Comprehensive Transplant Center (CTC) Human Tissue Biorepository at OSU and maintained in RPMI supplemented with 10% FBS, HEPES, L-glutamine, penicillin/streptomycin. The demographics of the HAMs are shown in Supplementary Table 1. BEAS-2B cell lines were purchased from ATCC (#CRL-3588), and were maintained in HITES media, which consisted of DMEM/F12 (Gibco, #11320033) supplemented with 10% FBS, insulin, transferrin, hydrocortisone, β-estradiol, HEPES, L-glutamine and penicillin/streptomycin. HEK-293T (ATCC, # CRL-3216) cells were cultured in DMEM supplemented with 10% FBS, HEPES, L-glutamine, and penicillin/streptomycin. THP1-Dual and THP1-Dual knockout (KO) TLR4 cell lines were purchased from InvivoGen (# thpd-kotlr4) and maintained according to the instructions in DMEM medium supplemented with selection antibiotics. THP1 and murine alveolar macrophage (MH-S) cells were purchased from ATCC (#CRL-2019) and maintained in RPMI complete medium, which contains 10% FBS, HEPES, sodium pyruvate, penicillin/streptomycin. THP-1 cells were differentiated into macrophage-like cells using phorbol 12-myristate 13- acetate (PMA, 80 ng/ml) for 24 h in RPMI complete medium. Human Peripheral Blood CD14+ monocytes were purchased from LONZA (#2W-400C), were maintained according to LONZA’s recommendations and were differentiated into macrophages using 50 ng/ml granulocyte-macrophage colony-stimulating factors (GM-CSF) for 7 days. BLaER1, human B-cell precursor leukemia cell lines were purchased from Sigma-Millipore (#scc165), were maintained according to company’s recommendations, and were transdifferentiated with 100 nM 17-beta estradiol (Sigma # E2758), 10 ng/ml of human IL-3 (Fisher Scientific, #200031), and 10 ng/ml of human M-CSF (Fisher Scientific, #30025) to induce the transgene C/EBPα. The medium and cytokines are replaced every 3 days, and the cells are transdifferentiated for 8 days in total. Primary mouse BMDM were isolated from tibias and femur of female and male mice. Bone marrow was collected and lysed with ACK buffer (Gibco, #A1049201) for 8 min and spun down at 200 x g for 10 min. The cell pellet was resuspended in complete media containing D-MEM with 10%FBS, 1% penicillin/streptomycin, and murine M-CSF (20 µg/ml, Biolegend, #576404) and differentiated for 7 days before experiments. Primary mouse alveolar macrophages were isolated according to a previously described protocol51. In short, lungs were flushed 10 times with pre-warmed 1 ml PBS + 2 mM EDTA and 0.5% FBS solution. The solution was recovered and pooled by filtering through 70 µm strainers (BD Falcon, #352350). After centrifugation at 300 × g for 5 min, cells were lysed with ACK buffer for 5 min and spun down at 300 × g for 5 min. Cell pellets were resuspended in complete media containing RPMI-1640 with 10% FBS, GlutaMAX, 1% penicillin/streptomycin and 20 ng/ml murine GM-CF (PeproTech, #315-03). For the first 18 h gentamicin was added to the culture media as well. Mouse alveolar macrophages were differentiated for 7–10 days before being used for experiments. Infectious agents The strains of H. influenzae serotype B (HiB; ATCC #10211), serotype A (HiA; ATCC #9006), and nontypeable (NTHi; ATCC #49247) were obtained from ATCC and stored in glycerol stocks in brain heart infusion (BHI) broth supplemented with Fildes enrichment with a 20% final glycerol concentration at −80 °C. Two days prior to the infection, the strains were seeded onto chocolate agar plates. Individual colonies of each species from chocolate agar plates were cultivated in BHI broth, and the cultures were incubated at 37 °C with 5% CO2 overnight. The bacterial optical density at 600 nm (OD600) was determined using a Nanodrop One (Thermo Fisher Scientific), and the samples were further diluted to the desired colony-forming units per milliliter (CFU/mL) in cell culture medium free of penicillin/streptomycin for in vitro treatment or in sterile PBS resuspended for in vivo experiments. Lipooligosaccharide (LOS) was extracted from HiB cells according to the method of Yi et al.52. Briefly, cells from overnight cultures were centrifuged, and the pellet was resuspended in 200 μL Trizol reagent. Chloroform was added at 40 μL/mg to the cell pellet, and the mixture was vortexed vigorously and incubated at room temperature for 10 min to facilitate phase separation. The sample was centrifuged at 12,000 × g for 10 min at 4 °C, and the aqueous phase containing LOS was collected. The organic phase was re-extracted twice with 100 μL of distilled water each time, combining all aqueous phases to ensure complete recovery of LOS. LOS was precipitated from the combined aqueous phases by adding ice-cold 0.375 M MgCl₂ in 95% ethanol to achieve a final ethanol concentration of 75%, followed by incubation at −20 °C for 1 h. The precipitated LOS was collected by centrifugation at 12,000 × g for 15 min at 4 °C, air-dried, weighed, resuspended in sterile water, aliquoted, and stored at −20 °C. For cell-free conditioned medium (CFCM) treatment, the bacteria were removed from overnight cultures by centrifugation at 8000 × g for 10 min and the cell-depleted broth was separated and heated at 90 °C for 1 min and added to treatment wells for indicated MOI equivalence and times. Treatment of myeloid cell lines with TLR Agonist A human TLR agonist kit was obtained from Invivogen (Human TLR1-9 Agonist Kit, Invivogen, # tlrl-kit1hw). Each individual ligand was diluted as per the manufacturer’s instructions, and the cells were subsequently challenged at concentrations specified in Supplementary Fig. 5a for 6 h. Stimulation of THP-1 macrophage cells and cytokine analysis THP-1 macrophage cells were cultured in RPMI media containing 10% FBS in the presence or absence of different bacterial subtypes at the indicated concentrations at 37 °C with 5% CO2. For blocking studies, THP-1 macrophage cells were pretreated with various concentrations of anti-TLR2 (Invitrogen, #mab2-mtlr2), anti-TLR4 (Invitrogen, #mabg-htlr4-2) blocking antibodies, or an isotype (IgG2a, Invitrogen, #mabg2a-ctrlm) control antibody for 1 h prior to stimulation with 500 ng/mL LOS for 6 h. For TLR4 decoy studies, 50 ng of LOS was preincubated with either a vehicle control (PBS containing 0.1% bovine serum albumin; BSA) or a recombinant human TLR4/MD-2 complex (R&D System, #3146-TM) for 1 h, after which it was added to THP-1 cells for stimulation for 6 h. The collected supernatants were centrifuged at 3000 × g for 15 min at 4 °C to remove cell debris and subsequently stored at −20 °C until they were assayed. The levels of IL-1β and TNFα were measured by using individual ELISA kits according to the manufacturer’s instructions (Invitrogen, #88-7261-88, #88-7346-88, respectively). The concentration and absorbance values are expressed as the means of duplicate or triplicate samples, with the standard deviation indicated. Generation of THP-1 macrophage cells stably expressing FBXO24-3xFlag Lentivirus was produced in HEK-293T cells and packaged with either an empty pCDH-EF1 plasmid or a plasmid expressing FBXO24-3xFlag and a 3rd generation triple-plasmid system that was subsequently utilized for the transduction of THP-1 cells. Successfully transduced cells were selected using blasticidin, and the resulting stable cell lines were cultured in RPMI media. To maintain the stability and purity of the stable cells, blasticidin selection was conducted every 4–6 months. All tissue culture supplies were purchased from Gibco. mRNA expression analysis To analyze changes in gene expression cells were lysed and processed using the RNeasy Plus Kit (Qiagen, #74192) according to the manufacturer’s protocol. To analyze gene expression in mouse tissues, tissue was homogenized in QIAzol (Qiagen) using the gentleMACSTM tissue dissociator with gentleMACS C- Tubes (Miltenyi Biotec, #130-096-334) and miRNeasy mini kit according to manufacturer’s instructions (Qiagen, #217004). Reverse transcription reactions generated cDNA using the High-Capacity RNA-to-cDNA™ (Applied Biosystems, #4387406). Expression levels were quantified by RT-qPCR using the SYBR Green system on CFX96 Real-Time System (Bio-Rad). A list of primers is provided in Supplementary Table 2. Site-directed mutagenesis The mutations were generated by site-directed mutagenesis. The FBXO24 mutants were created using PCR and overlapping primers, as detailed in Supplementary Table 2. All primers were designed using SnapGene and synthesized by Integrated DNA Technologies. The sequences of all plasmids were confirmed by sequencing at the Genomic Core at OSU, and protein expression was validated in vitro. FBXO24 half-life and degradation pathway HAMs, either uninfected or infected with HiB for a period of 4 h, were treated with the protein synthesis inhibitor CHX at a concentration of 40 µg/ml with or without HiB (10 MOI) for 0 to 8 h to establish the half-lives of endogenous expressed FBXO24. Similarly, to determine the effect of HiB infection on the half-life of exogenously expressed FBXO24 protein, we treated THP-1 macrophages stably overexpressing FBXO24-Flag with CHX under conditions with or without HiB infection for up to 6 h. To investigate the degradation pathways of FBXO24, cells were treated with the proteasome inhibitor MG132 (5 µM, UBP Bio, #F1101), lysosome inhibitor Baf-A1 (100 nM, Sigma-Aldrich, #B1793) or the ubiquitin activating enzyme inhibitor MLN 7243 (5 µM, Chemie Tek, #CT-M7243). Immunoblotting The cells were lysed using Protein Lysis Buffer A (PBS, 0.2% SDS, 0.05% 100X-Triton), and Pierce Protease Inhibitor cocktail, (Thermo Scientific, A32963) and subjected to sonication for 20 sec at 25% using a VibraCell Sonicator (Sonics). Lung tissues from mice were homogenized in Protein Lysis Buffer A (300 mg tissue/1 ml lysis buffer) using a gentle MACSTM tissue dissociator with gentle MACS C- Tubes (Miltenyi Biotec). Protein quantification was performed using the Lowry assay. Subsequently, the samples were combined with Laemmli buffer and subjected to electrophoresis on SDS-PAGE gels. Next, the proteins were transferred to nitrocellulose membranes using the Trans-Blot Turbo Transfer system. The membranes were blocked with 5% milk for 30-60 min at RT, after which they were incubated overnight with the indicated antibodies. Antibodies used for immunoblotting were human anti-FBXO24 (Novus, #NBP1-53141, 1:2000; LSBio, #LSC166082,1:1000), human anti-USP4 (Abcam, #ab181105, 1:1000), anti-FBXL14 (Proteintech Group, #13934-1-AP, 1:1000), anti-FBXO5 (Abnova, #MAB13276, 1:1000), anti-FBXO3 (Santa Cruz, #sc-514625, 1:2000), anti-β-actin (Abcam, #ab8226, 1:5000), anti-c-myc (Cell Signaling, #5605S, 1:1000), anti-flag (Abcam, #ab125243, 1:1000), anti-ubiquitin (Abcam, #ab134953, 1:1000 dilution), anti-p65 (Cell Signaling, #4764, 1:2000), anti-STAT1 (Cell Signaling, #9172, 1:2000), anti-IFIT3 (Santa Cruz, #sc393396, 1:2000), and anti-CD206 (Novus, #NBP2-66956, 1:2500). Subsequently, the membranes were developed using WesternBrightTM peroxidase (Advansta) and imaged using a ChemiDoc Imager (BioRad). Membrane from mouse lung tissue was stained with PonceauS (Sigma) for 5 min and imaged. Total protein loading was assessed using stain-free technology (BioRad). All immunoblotting supplies were obtained from Bio-Rad, and densitometric analysis was conducted using Image Lab (Version 6.1) software, Bio-Rad. Subsequently, the membranes were developed using WesternBrightTM peroxidase (Advansta) and imaged using a ChemiDoc Imager (BioRad). All uncropped and unprocessed scans of full-scan immunoblots are provided in the Source Data file. Immunoprecipitation To ascertain the levels of protein ubiquitylation, THP-1 macrophage cells overexpressing FBXO24-Flag (or mutant versions of this protein) or control cells were infected with HiB at the indicated MOI for up to 6 h or with HiB at variety of MOI for 6 h. An hour before the cells were collected for lysis, the cells were treated with the proteasome inhibitor MG132 and the lysosome inhibitor Baf-A1 for 6 h to block degradation of ubiquitylated proteins. Next, cells were lysed in lysis Buffer A supplemented with DUBs and a protease inhibitor cocktail and normalized as mentioned earlier in the immunoblotting. The lysates were incubated while rotating with anti-Flag M2 Magnetic Beads (Sigma-Aldrich, #M8823)) at RT for 2 h to capture immunoprecipitated FBXO24. The beads were then washed with phosphate-buffered saline (PBS) containing 0.2% Tween-20, and then the elution was carried out in 2x Laemmli buffer via boiling. The eluted IP and input samples were subsequently subjected to immunoblotting. Mass spectrometry (MS) analysis To identify ubiquitin acceptor residue(s) by MS analysis, THP-1 macrophage cells expressing FBXO24-Flag were infected with 10 MOI of HiB for 6 h. Infected and uninfected samples as control were then subjected to IP as described above for four biological repeats. Ubiquitylated peptides were identified by MS analysis conducted by the Proteomics Facility at the OSU Campus Chemical Instrument Center. The beads were washed three times with 50 mM ammonium bicarbonate, then subjected to on-beads digestion overnight prior to cleanup purification for subsequent analysis using LC/MSMS analysis. Nano-liquid chromatography-nanospray tandem mass spectrometry (Nano-LC/MS/MS) of protein identification was performed on a Thermo Scientific Orbitrap Eclipse mass spectrometer equipped with a nanospray FAIMS Pro™ Source. The instrument was operated in positive ion mode. Samples (6.4 µl) were separated on an easy spray nano column (PepmapTM RSLC, C18 3 µ 100 A, 75 µm X150mm Thermo Scientific) using a 2D RSLC HPLC system from Thermo Scientific. Each sample was injected into the µ-Precolumn Cartridge (Thermo Scientific) and desalted with 0.1% formic acid in water for 5 min. The injector port was then switched to inject, and the peptides were eluted off of the trap onto the column. Mobile phase A was 0.1% formic acid in water and acetonitrile (with 0.1% formic acid) was used as mobile phase B. Flow rate was set at 300nL/min. mobile phase B was increased from 2% to 16% in 105 min and then increased from 16-25% in 10 min and again from 25-85% in 1 min and then kept at 95% for another 4 min before being brought back quickly to 2% in 1 min. The column was equilibrated at 2% of mobile phase B (or 98% A) for 15 min before the next sample injection. MS/MS data was acquired with a spray voltage of 1.95 kV and a capillary temperature of 305 °C. The scan sequence of the mass spectrometer was based on the preview mode data-dependent TopSpeed™ method. The analysis was programmed for a full scan recorded between m/z 375-1500 and a MS/MS scan to generate product ion spectra to determine amino acid sequence in consecutive scans. To achieve high mass accuracy MS determination, the full scan was performed at FT mode and the resolution was set at 120,000 with internal mass calibration. Three compensation voltage (cv = -40, -60 and -80v) were used for samples acquisition. The AGC Target ion number for the FT full scan was set at 4 x 105 ions, maximum ion injection time was set at 50 ms and the micro scan number was set at 1. MSn was performed using HCD in ion trap mode to ensure the highest signal intensity of MSn spectra. The HCD collision energy was set at 28%. The AGC Target ion number for ion trap MSn scan was set at 3.0E4 ions, maximum ion injection time was set at 35 ms and the micro scan number was set at 1. Dynamic exclusion is enabled with a repeat count of 1 within 30 s and a low mass width and high mass width of 10 ppm. The resulting mgf files, generated from the samples, were searched using Mascot Daemon by Matrix Science, version 2.7.0 (Boston, MA), against appropriate databases using the Proteome Discoverer (Thermo Fisher Scientific) platform. The mass accuracy of the precursor ions was set to 10 ppm, and the accidental pick of 1 13 C peaks was also included in the search. The fragment mass tolerance was set to 0.5 Da. The following variable modifications were considered: oxidation (Met), deamidation (N and Q), ubiquitylation (K), and phosphorylation (ST), as well as carbamidomethylation (Cys) as a fixed modification. Four missed cleavages for the enzyme were permitted. A decoy database search was also conducted to determine the false discovery rate (FDR), and peptides were filtered according to the FDR. The significance threshold was set at p < 0.05, and the presence of bold red peptides was required for valid peptide identification. Proteins with an FDR of less than 1% and a minimum of two significant peptides detected were considered valid proteins. Label-free quantitation was performed using the spectral count approach in which the relative protein quantitation was measured by comparing the number of MS/MS spectra identified from the same protein in each of the multiple LC/MSMS datasets. Scaffold version 5.3.3 was utilized for the purpose of data analysis. The normalization scheme in Scaffold adjusted the sum of the selected quantitative value for all proteins in the list within each MS sample to a common value: the average of the sums of all MS samples presents in the experiment. This adjustment is achieved by applying a scaling factor to each sample, thereby normalizing the selected value to a quantitative value. The Student’s-t test, facilitated by Scaffold (Proteome Software, Portland, OR), was employed to ascertain the statistical significance of alterations in protein folder composition (P < 0.05). The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE53 partner repository with the dataset identifier PXD077990 and 10.6019/PXD077990. SEAP and Lucia luciferase activity assays The THP1-Dual KO-TLR4 cells were engineered to monitor innate immune pathways from the human THP1-Dual monocytic cell line through a biallelic knockout of the TLR4 gene. They include two inducible reporter genes, enabling simultaneous analysis of NF-κB and IRF pathways via SEAP and Lucia luciferase activities in supernatant. To evaluate the effect of HiB on the NF-κB activation, the THP1-Dual KO-TLR4 cells and control THP-1 Dual cells were stimulated with vehicle (PBS), HiB, CFCM, Pam3CSK4, and LOS for 6 h. Supernatants were collected, and NF-κB activation was determined using the QUANTI-Luc 4 assay kit and IRF3 activation was determined using QUANTI-Blue assay kit, in accordance with manufacturer’s instructions (InvivoGen, # rep-qbs). DUB siRNA library screening Human ON-TARGETplus siRNA library targeting 96 DUBs genes consisting of SMARTpool siRNA (four individual siRNAs targeting each gene) in a 96-well format was purchased from Horizon Discovery Ltd (G-104705-05). Generation of BEAS2B stably overexpressing FBXO24-HiBiT was achieved using the Sleeping Beauty transposon system. HiBiT, an 11-amino acid epitope tag, is capable of producing a bioluminescent signal when bound to its complementation partner, LgBiT. To identify the binding partner of FBXO24, BEAS-2 stably overexpressing FBXO24-HiBiT cells were seeded at a density of 5 × 105 cells per well in 96-well plates. The cells were then transfected with 96 distinct DUB SMARTpool siRNAs and nonspecific siRNA as controls at a concentration of 50 nM using GeneMute Reagent for 48 h according to the manufacturer’s instructions. Luciferase in the cell lysate was detected using the Nano-Glo HiBiT Lytic Detection System (Promega, # N3030) following the manufacturer’s instructions. Briefly, 100 µl of Nano-Glo HiBiT Lytic Detection Reagent was added directly to the cells and incubated for 5 min on an orbital shaker (300 rpm) before recording luminescence on a Synergy H1 microplate reader (Biotek) with 0.2 s integration time. TUBEs assay Ubiquitin IP to detect ubiquitylation of endogenous FBXO24 protein in USP4 overexpressing or control THP-1 macrophage cells was performed under non-denaturing conditions. Lysates were harvested in PBS + 0.5% TritonX-100 buffer containing tandem ubiquitin binding entities (TUBEs), which bind to ubiquitin chains. We used biotin-tagged TUBEs that specifically bind to all ubiquitin chains (Life Sensors, #UM301). Biotin-tagged TUBEs are immunopurified from lysates using Streptavidin magnetic beads (Pierce, #88817) using the manufacturer’s protocol. Confocal imaging and analysis FBXO24-Flag overexpressing THP-1 macrophage cells were plated at 1 × 105 cells per well on culture slides (Lab-Tek) and differentiated with 80 ng/ml PMA overnight. The cells were infected with HiB (10 MOI) or mock (bacterial culture media) for 6 h. Cells were treated with leupeptin (100 µM) to inhibit protein degradation for the last 2 h of the treatment. Cells were fixed in 4% paraformaldehyde/PBS for 10 min, permeabilized with 0.1% Triton X-100/PBS for 10 min, and blocked with 1% BSA for 30 min. Subsequently, cells were stained with primary antibodies including anti-Flag (1:50, Sigma-Aldrich, #F1804), and anti-Lamp1 (lysosomal marker, 1:50, R&D System, #NL4800R) at 4 °C overnight, followed by fluorescent secondary antibody, goat anti-mouse IgG1 Alexa Fluor 594 (1:50, Invitrogen, #A-21125, for Flag) and goat anti-mouse IgG2b Alexa Fluor 488 (1:50, Invitrogen, #A-21141, for Lamp1) at RT for 4 h. Finally, 4’,6-diamino-2-phenylindole (DAPI, Invitrogen, #D1306) counterstaining was performed, and images were acquired on the Evident Scientific FV3000 Multi Confocal Microscope system using an inverted Olympus IX83 confocal microscope with ×60 oil PlanApo N SC, 1.40 N.A., 0.15 mm W.D. objective (Evident Scientific MIS). Images were assembled with Fiji (ImageJ), and image analysis was done with Fiji using colocalization plugin. Colocalized area (Flag + / Lamp1+ area) was calculated as percentage of total cell area. BAL cells from mice with siRNA-loaded MLNP were spun at 500 × g for 5 min using cytospin-centrifuge, slides were fixed in 4% paraformaldehyde/PBS for 10 min, permeabilized with 0.1% Triton X-100/PBS for 10 min, and blocked with 1% BSA/PBS for 30 min. Subsequently, cells were stained with primary Usp4 antibody (1:100, Abcam, #ab181105) at 4 °C overnight, followed by fluorescent secondary goat- anti rabbit Alexa Fluor 647 antibody (1:50, Invitrogen, #A-21244) at RT for 4 h. Finally, 4’,6-diamino-2-phenylindole (DAPI) counterstaining was performed, and 15 randomly chosen images/slide/mouse were acquired on the Evident Scientific FV3000 Multi Confocal Microscope system using an inverted Olympus IX83 confocal microscope with ×60 oil PlanApo N SC, 1.40 N.A., 0.15 mm W.D. objective (Evident Scientific MIS). Images were assembled and analyzed with Fiji (ImageJ). Corrected total cell fluorescence was calculated by measuring the integrated density of Usp4 fluorescence and area of cell. Background fluorescence was measured on three areas/picture and averaged. Formula used: CTCF = Integrated Density−(Area of selected cell × mean of fluorescence of background reading). Generation of USP4 KD and KO THP-1 macrophage cells Interfering RNA technology was used to transiently knock down USP4 in THP-1 cells with USP4-specific siRNA or a nonspecific siRNA (Supplementary Table 2). CRISPR/Cas9 technology was used to knock out USP4 in THP-1 cells. Lentivirus was generated in HEK-293T cells using an all-in-one plasmid (lentiCRISPR v2) harboring Cas9 and USP4-specific sgRNA or nonspecific sgRNA and a third-generation triple-plasmids system for packaging lentivirus. Stably USP4 knockout THP-1 cells were selected by puromycin resistance. Endogenous DUB activity assay To determine USP4 activity in WT and TLR4-KO dual THP-1 cells, we used ubiquitin-vinyl sulfone (HA-tagged) probes (Enzo, #BML-UW0155). PMA-differentiated THP-1 Dual cells (WT or TLR4-KO) were infected for 6 h with HiB at an MOI of 10:1. Cells were lysed in 0.1%NP-40, 150 mM NaCl, 20 mM CaCl2, 50 mM Tris pH 7.4 buffer containing 1 mM phenylmethanesulfonylfluoride (PMSF). Samples containing equal amounts of protein were subjected to the enzymatic reaction with the ubiquitin vinyl sulfone HA-tagged probe at a final concentration of 5 µM for 45 min at 37 °C. Activated DUBs were pulled down using HA-tag magnetic beads (Pierce, #88836). The difference in USP4 activity between groups was measured by densitometric quantification of endogenous USP4 detected on immunoblots. Phagocytosis assay The phagocytosis assay was performed using a phagocytosis assay kit (Abcam, Red Zymosan, #ab234054). USP4 and control knockout THP-1 cells were differentiated into macrophages-like cells using PMA (80 ng/ml) for 24 h in RPMI complete media in 96-well plates. The control cells were pretreated with 20 µM of cytochalasin D (Sigma-Aldrich, #C8273) for 1 h. All cells were treated with Zymosan slurry (5 µl) for 2 h. Cells were washed accordingly, and Zymosan-positive cells were evaluated by fluorometric plate reader at Ex/Em at 540/570 nm, respectively. Fabrication of mannose-conjugated lipid nanoparticles (MLNPs) We produced the MLNPs with 9.3% of 1,2-dipalmitoyl-sn-glycero-3-phospho((ethyl-1’,2’,3’-triazole)triethyleneglycolmannose) (PA-PEG3-M, Avanti Research, #870292 P) lipid. The MLNPs were prepared using the ethanol injection and sonication method54. MLNPs were fabricated by the ethanol injection and sonication method as described previously27. Briefly, a mixture of lipids including DOPE (Avanti Research, #850725 C), DOTAP (Avanti Polar Lipids, #890890 P), LA (Sigma-Aldrich, #1376), and PA-PEG3-mannose (Avanti Polar Lipids, #870292) were dissolved in ethanol at a molar ratio of 40:10:48:10. The mixture was injected into 20 mM HEPES buffer and then sonicated to form empty MLNPs containing 9.3% PA-PEG-mannose. siUsp4 or siRNA non-targeting (NTC) control (Dharmacon Reagents, Horizon) were mixed with PEI at an N:P ratio of 1:25 (the ratio of moles of PEI amine groups to nucleic acid phosphate groups) in HEPES buffer and incubated at room temperature for 10 min to form PEI/siRNA polyplexes. The empty nanoparticles and polyplex solutions were then mixed at a lipid-to-nucleic acid final mass ratio of 25, and this mixture was sonicated for 5 min and then incubated for 10 min at room temperature. For physicochemical characterization of MLNP, particle size and polydispersity index (PDI) were measured by dynamic light scattering (DLS) using a Zetasizer Advance Lab DLS/ELS Systems (Malvern Panalytical, Malvern, UK). Nanoparticles were diluted to a ratio of 1:100 with distilled water. Zeta potential was determined by laser Doppler velocimetry (LDV) using Zetasizer Advance Lab DLS/ELS Systems. Experiments were performed three times. The particle size and zeta potential of both MLNP formulations are shown (Supplementary Fig. 18a, b). The average diameter of the siNTC-MLNP as determined by dynamic light scattering was 267.2 ( ± 2.8) nm with PDI of 0.2862 (Supplementary Fig. 18a, b). The siUsp4-loaded MLNP had an average diameter 169.9 ( ± 4.2) nm and PDI of 0.1562 (Supplementary Fig. 18a, b). The zeta potential of the lipid nanoparticles shifted from negative to positive after loading of the positively charged PEI/siRNA complex (Supplementary Fig. 18b). Incorporation efficiency was determined by agarose gel electrophoresis. Briefly, siRNAs-loaded MLNPs were lysed with 0.5% sodium dodecyl sulfate (SDS) (BioRad, Hercules, CA) and loaded onto 2% agarose (Fisher BioReagents) gel containing Labsafe nucleic acid stain (GBiosciences). siRNAs loaded MLNPs without SDS were also loaded into the gel for comparison. Gel electrophoresis was run at 120 V for 45–60 min. Images of the gel were captured under UV light using ChemiDoc Imaging System (Bio-Rad). Incorporation efficiency was calculated using Image J. The formula used was: %Incorporation efficiency = [(total siRNA amount–unincorporated siRNAs)/total siRNA amount × 100%. Encapsulation efficiency measured by agarose gel electrophoresis indicated nearly all of siRNA was encapsulated in the MLNP (Supplementary Fig. 18b). Generation of FBXO24 transgenic mice Fbxo24+/− mice were generated using CRISPR/Cas9 technology at the University of Pittsburgh. In summary, guide RNAs were designed and tested in blastocysts. CRISPR/Cas9 RNA constructs were then injected into fertilized mouse eggs at the University of Pittsburgh Transgenic and Targeting core facility. These embryos were subsequently implanted into pseudo-pregnant females. The generation of the Fbxo24+/− mice was confirmed by DNA sequencing and restriction fragment length polymorphism analysis10. Experimental pneumonia All animal experimental research complied with all relevant ethical regulations and was approved by The Ohio State University Institutional Animal Care and Utilization Committee under protocol number 2019A00000019-R2. Mice were housed in the OSU ULAR vivarium on a 12 h light/dark cycle at a temperature of 65–80 °F and 30–70% humidity. C57BL/6 J mice used for the study were 10–16 weeks old. For intranasal HiB infection, mice were anesthetized with isoflurane and HiB (50 μl) or PBS (control) was administered into the nostrils using a micropipette. For intratracheal (i.t.) administration of siRNA-loaded MLNPs, mice were anesthetized with isoflurane and positioned on a 45° angled stand. Under visualization of the vocal cords, the trachea was intubated with a 22 g catheter, and 100 μl of siRNA-loaded MLNPs (i.e., 2.5 nmol siRNA/mouse) was i.t. instilled into the lungs of mice 6 h before intranasal HiB infection. For macrophage depletion/BMDM reconstitution studies, on day 0 mice received 0.2 ml of Clodrosome (Encapsula NanoSciences, #CLD-8901) by intravenous (i.v.) retroorbital delivery using a 27 g needle; Encapsomes were used in the same dose as clodronate liposomes. On day 2, mice received 1 × 106 cultured CM-DiI labeled BMDM cells by i.v. retroorbital injection, and a sham injection with PBS was done for the control group. BMDM cells were isolated from male and female Fbxo24+/+ and Fbxo24−/− mice and differentiated with mouse M-CSF for 7 days. CM-Dil labeling was done with CellTrackerTM CM-DiI Dye from Invitrogen (#C7001) according to manufacture’s instructions. On day 4, HiB was administered intranasally for 24 h. Mice were euthanized with CO2 and cervical dislocation. Bronchoalveolar lavage (BAL) was collected by exposing the trachea, creating an incision, and inserting a blunted needle into the trachea. The lungs were then flushed with 1 mL 0.1 mM EDTA/ PBS. Right lungs were collected for protein, mRNA and bacterial CFU assays. Left lungs were inflated with 10% formalin at a pressure of 20 cm H2O. To verify the selective targeting of alveolar lung macrophages by siRNA-MLNPs, heart, liver, spleen, and kidney were collected and subjected to RT-PCR analysis of Usp4 gene expression. BAL was then centrifuged at 300 × g for 10 min and fluid supernatant was transferred to a fresh tube for determination of mouse albumin by ELISA (FORTIS® Life Science, #E99-134) and cytokines via multiplex ELISA (Meso Scale Discovery, V-Plex mouse cytokine 19-Plex kit, #K15255D) and cytokine ELISAs for active mouse TGFβ1 (R&D System, #DB100C), mouse IL-1R (R&D System, #MRA00) and mouse prostaglandin E2 (R&D System, #KGE004B). The remaining cell pellet was resuspended in 200 µL ACK solution (Gibco) and incubated on ice for 10 min to lyse red blood cells. To stop the reaction, 1 mL PBS was added, and the solution was centrifuged at 800 × g for 10 min, supernatant was aspirated, and cells were resuspended in 400 µL PBS for differentials. Total cell counts were performed with trypan blue. 100 µL of cell suspension was spun down for cytospins at 500 × g for 5 min using cytology funnel slides. Slides were processed with modified Giemsa staining (Sigma-Aldrich, #GS500) and May-Grünwald staining (Sigma-Aldrich, #MG500). 100 cells/slide were counted and scored as polymorphonuclear (PMN) or mononuclear (MN) cells; the percentage average of counts was multiplied by the total cell count and expressed as the number of cells. BAL cells were used for cytospins for confocal Usp4 immunofluorescence staining and flow cytometry for Fbxo24 and immune cell panel staining. To determine bacterial load, mouse lungs were weighed before being homogenized in 1 ml PBS using gentleMACSTM tissue dissociator with gentleMACS C-Tubes (Miltenyi Biotec). Serial dilution of lung homogenate was performed, and 5 μL from each dilution was plated on marked sections of a chocolate agar plate. The first dilution to display individual colonies was used to calculate bacterial loads. For Clodronate macrophage depletion studies, single cell suspensions were prepared from mouse spleens and bone marrows. For splenic single cell isolation, a mechanical digestion of the tissue was performed by crushing the spleen 5-times with a syringe plunger in dissociation media containing PBS with 2% FBS and 1 mM EDTA. Second, a single cell suspension was generated by passing the minced tissue solution through a 70 µm cell strainer. After centrifugation at 300 × g for 10 min, the cell pellet was resuspended in 1 ml ACK buffer for 2 min. Cells were centrifuged at 300 × g for 10 min and resuspended in flow buffer containing PBS with 2% FBS. Bone marrow single cell suspensions were isolated as described for BMDM culture isolation. Single cells from spleen and bone marrow were used for F4/80 macrophage staining by flow cytometry. Female and male Tlr4−/− mice were purchased from The Jackson Laboratories as live animals at age 8–12 weeks. The strain was: B6(Cg)-Tlr4tm1.2Karp/J, strain ID 029015. More detailed information can be found on the Jackson Laboratories website. Flow cytometry For immune cell panels with FBXO24 staining, freshly isolated BAL cells were stained with LIVE/DEAD fixable green staining for 30 min (1:1000, Invitrogen, #L23101). Cells were washed twice: once with PBS and once with flow buffer (PBS + 2% FBS) and centrifuged for 5 min at 500 × g. Cell pellets were suspended in 100 µl flow buffer and blocked using TruStain FcX™(1:100, BioLegend, #101319) for 5 min on ice. For immune staining, cells were stained with antibody mix for CD45 (0.5 µg, clone 30-F11, Brilliant Violet™ 650 conjugated, eBioscience™, #416-0451-82), CD11b (0.5 µg, clone M1/70, APC/Cy7 conjugated. BioLegend, #101226), CD64 (0.5 µg, clone X54-5/7.1, PE-Cy7 conjugated, Biolgend, # 139314), Ly6G (1 µg, clone 1A8, BD OptiBuild™ BV480 conjugated, BD Bioscience, #746448), Ly6C (0.5 µg, clone HK1.4, eFluor™ 450 conjugated, eBioscience™, #48-5932-82), SiglecF (0.25 µg, clone S18007L, PE conjugated, BioLegend, #155506) and MHCII (0.25 µg, clone M5/114.15.2, BD Horizon™ RB705 conjugated, BD Bioscience, #570619) for 30 min on ice. Cells were centrifuged at 500 × g for 5 min and washed with flow buffer. Cytofix/ cytoperm (BD Biosciences, #554714) was used for fixation/permeabilization for 20 min on ice. Cells were stained with primary Fbxo24 antibody (1:50, LSBio,#LSC166082) prediluted in 1× perm/wash buffer (BD Biosciences, #554723) for 30 min on ice and secondary anti-rabbit Alexa Fluor 647 (1:50, Invitrogen, #A-21244) for 20 min on ice. Cells were acquired with a BD FACSymphony™ A1 Cell Analyzer (BD Biosciences). FlowJo (BD Biosciences) was used for gating and analysis, in detail, cells were gated for side (SSC-A) and forward scatter (FSC-A). Aggregates were excluded by gating FSC-H vs. FSC-A and SSC-W vs SSC-H. Live cells were gated for FSC-H vs Alexa Fluor 488. FBXO24+ cells were gated in FSC-A vs Alexa Fluor 647. CD45+ cells were gated SSC-A vs BV650. For neutrophil+ cells, CD45+ cells were further gated for CD11b+ APC/Cy7 vs Ly6G+ BV-480 cells. For monocyte/macrophage subpopulations, CD45+ cells were further gated for CD64+ PE/Cy7 vs CD11b+/− APC/Cy7 cells. Ly6G+ cells were excluded by gating CD64 PE/Cy7 vs Ly6G BV-480. SiglecF− and SiglecF+ cells were gated in CD64 APC/Cy7 vs SiglecF PE. BMDMs were gated from SiglecF− cells for MHC-II− RB705 vs Ly6Chigh eFluor450. MDM and resident alveolar macrophages (RAM) were gated from SiglecFhigh cells. For live/dead cell compensation ArC™ Amine Reactive Compensation bead kit (Invitrogen, #A10628) was used, and for all other surface and intracellular staining, UltraComp eBeadsTM Plus compensation beads were used (Invitrogen, #01-3333-41). A positive population gate was set using isotype-matched control and positive staining in a pseudocolour plot. The population was calculated as percentage positive versus parent cells (single cells). Total FBXO24+ BAL cell populations for neutrophils, BMDM, RAM and MDM were calculated by positive cells versus live cells, then multiplied by total BAL cell counts. For FBXO24 MFI calculations, FBXO24+ staining was shown as a histogram, and MFI was calculated by the mean of Alexa Fluor 647 staining. For clodronate depletion/ reconstitution studies to include gating for CM-DiI+ cells, the LIVE/DEADTM Fixable Near-IR stain kit (Invitrogen, # L34976), CD11b (0.5μg, clone M1/70, Alexa Fluor® 647 conjugated, BioLegend, # 101218) and SiglecF (0.25 μg, clone S17007L, Alexa Fluor® 488 conjugated, BioLegend, # 155524) were used instead of described above. For F4/80+ macrophage flow staining and gating in splenic and bone marrow single cells, cells were blocked with TruStain FcXTM (1:100, BioLegend, # 101319) for 5 min on ice and stained with F4/80 (0.5 μg, clone BM8, APC conjugated, BioLegend, # 123116) for 30 min on ice. Cells were washed with flow buffer and stained with 7-AAD (0.25 μg, BD Bioscience, # 559925) for live/dead stain. For details on gating, cells were gated FSC-A vs. SSC-A, and cell aggregates were removed by gating for FSC-H vs. FSC-A. Live cells were gated by FSC-H vs. 7-AAD− cells. F4/80+ cells were gated in SSC-A vs. F4/80 APC. Positive cell populations were shown in pseudoplots and calculated as the percentage F4/80+ cells of parent (live) cells. Lung histology and ALI scoring Left lungs were fixed in 10% formalin for 72 h. Then 4-transversal sections were cut with a scalpel for each mouse lung. Lung sections were processed for paraffin embedding, and 4 μm sections were stained for H&E (Histowiz). Whole H&E-stained slides were scanned. For analysis, 20 randomly chosen pictures were taken using ×10 magnification over all four transversal sections. Images were scored by blinded investigators. ALI scoring was done according to Aeffner et al.55. Cathepsin D assay and cell counts THP-1 macrophage cells were infected with HiB (MOI = 0–10 for 6 h). Cells were removed from culture plates using trypsin and counted with a TC20 automated cell counter (BioRad) with a 1:2 dilution in Trypan Blue. For cathepsin D assays, cells were normalized to 0.5 × 106 cells/well. Cathepsin D assays (Abcam) were performed according to manufacturer instructions and read on a fluorometric plate reader (BioTek). Statistics and reproducibility All data are presented as mean ± SD unless otherwise stated, and tests are specified in the corresponding figure legends. The recommended tests for variance of standard deviations were used, and associated corrections were implemented as necessary. The number of experiments is indicated by n, where “n” represents separate biological experiments and not technical replicates. Unless otherwise stated, all statistical analyses were conducted using GraphPad Prism (GraphPad). No statistical method was used to predetermine sample size. No data were excluded from the analyses. The experiments were not randomized, and the investigators were not blinded to allocation during experiments and outcome assessment. Reporting summary Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article. Supplementary information Supplementary Information Reporting Summary Transparent Peer Review file Source data Source Data 1 Source Data 2 Source Data 3 Acknowledgements The authors acknowledge resources from the Campus Microscopy and Imaging Facility (CMIF) and the OSU Comprehensive Cancer Center (OSUCCC) Microscopy Shared Resource (MSR), The Ohio State University. This facility is supported in part by grant P30 CA016058, National Cancer Institute, Bethesda, MD. Human lung specimens were processed by Sean Stacey through The Ohio State University Wexner Medical Center Comprehensive Transplant Center Human Tissue Biorepository. Figs. 6a, 7a, h, 8c, and 9 were created with BioRender.com. Author contributions I.Y. and R.K.M. designed the study, analyzed the results, and wrote the manuscript. I.Y., A.C., D.F., S.X., J.A.E. and J.A.J. performed experiments and analyzed data. I.Y., A.C., D.F., B. S. J., and RKM edited the manuscript. J.D.L., J.S.B., and R.K.M. provided critical feedback and helped shape the research. R.K.M. directed the study. Peer review Peer review information Nature Communications thanks Emre Turer, and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. A peer review file is available. Funding This work was supported by NIH awards R01HL142767 to J.A.E. and P01HL114453, R01HL097376, R01HL081784, R01HL096376, and R35 HL182842-01 awarded to R.K.M. Data availability The immunoblots, qPCR, ELISA, and related data generated in this study are provided in the Source Data file. Full, unaltered immunoblots and original data files with preserved metadata are provided as a Source File and available upon request. Proteomic data from this study have been deposited in the ProteomeXchange database with the identifier PXD077990. Thus, all Source data are provided with this paper. Competing interests The authors declared no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Supplementary information The online version contains supplementary material available at 10.1038/s41467-026-75336-7. References Associated Data Supplementary Materials Supplementary Information Reporting Summary Transparent Peer Review file Source Data 1 Source Data 2 Source Data 3 Data Availability Statement The immunoblots, qPCR, ELISA, and related data generated in this study are provided in the Source Data file. Full, unaltered immunoblots and original data files with preserved metadata are provided as a Source File and available upon request. Proteomic data from this study have been deposited in the ProteomeXchange database with the identifier PXD077990. Thus, all Source data are provided with this paper.